4D Molecular Therapeutics (FDMT) Stock Chart & Stock Price History $4.65 +0.15 (+3.42%) As of 12:30 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock 4D Molecular Therapeutics Stock Price Performance The 4D Molecular Therapeutics (FDMT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 74.06%, with a year-to-date return of -16.45%. In the past month, the stock has increased 23.45%, reflecting recent market activity. As of the latest close, 4D Molecular Therapeutics traded at $4.50 with a market cap of $208.49 million and volume of 324,970 shares. Receive FDMT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+10.28%1 Month Performance+23.45%3 Month Performance+36.08%Year-To-Date Performance-16.45%1 Year Performance-74.06% FDMT Stock Chart for Wednesday, July, 23, 2025 FDMT Chart by TradingView 4D Molecular Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/22/2025$4.24$4.50+6.13%$4.50$4.21324,970 shs$208.49 million07/21/2025$4.22$4.24+0.47%$4.40$4.15317,779 shs$196.44 million07/18/2025$4.36$4.22-3.21%$4.45$4.17316,866 shs$195.51 million07/17/2025$4.26$4.36+2.35%$4.41$4.19275,862 shs$201.98 million07/16/2025$4.16$4.26+2.40%$4.34$4.20319,675 shs$197.37 million07/15/2025$4.38$4.16-5.02%$4.40$4.11248,920 shs$192.73 million07/14/2025$4.28$4.38+2.34%$4.42$4.24176,075 shs$202.93 million07/11/2025$4.35$4.28-1.61%$4.34$4.23183,304 shs$198.29 million07/10/2025$4.42$4.35-1.58%$4.50$4.34186,194 shs$201.51 million07/09/2025$4.22$4.42+4.74%$4.48$4.25299,294 shs$204.78 million Get the Latest News and Ratings for FDMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/08/2025$3.95$4.22+6.84%$4.24$3.98284,905 shs$195.51 million07/07/2025$4.10$3.95-3.54%$4.36$3.86290,583 shs$182.98 million07/04/2025$4.10$4.10$4.34$4.13196,317 shs$189.72 million07/03/2025$4.31$4.10-4.99%$4.34$4.13196,317 shs$199.66 million07/02/2025$4.15$4.31+3.86%$4.40$4.15619,419 shs$199.68 million07/01/2025$3.71$4.15+11.86%$4.19$3.68858,180 shs$192.27 million06/30/2025$3.84$3.71-3.39%$3.89$3.71235,825 shs$171.88 million06/27/2025$4.07$3.84-5.65%$4.09$3.801.44 million shs$177.91 million06/26/2025$4.08$4.07-0.25%$4.11$3.90229,814 shs$188.56 million06/25/2025$4.00$4.08+2.00%$4.13$3.80199,893 shs$189.03 million06/24/2025$3.77$4.00+6.10%$4.02$3.75343,716 shs$185.30 million06/23/2025$4.13$3.77-8.72%$4.17$3.73725,400 shs$174.66 million Related Companies CMRX Stock Price Chart CRON Stock Price Chart QURE Stock Price Chart OCS Stock Price Chart ANAB Stock Price Chart BGM Stock Price Chart CRMD Stock Price Chart VIR Stock Price Chart KALV Stock Price Chart AMLX Stock Price Chart Receive FDMT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:FDMT) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4D Molecular Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 4D Molecular Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FDMT Stock Alerts